ProfileGDS4718 / 205970_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 63% 64% 60% 65% 64% 66% 61% 69% 61% 67% 64% 57% 58% 59% 61% 63% 64% 58% 61% 54% 66% 64% 64% 64% 64% 57% 60% 59% 58% 62% 62% 56% 62% 63% 61% 59% 58% 65% 67% 60% 64% 60% 59% 58% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3151263
GSM549102patient 115, normal, homogenized [OPG study]6.3974864
GSM549104patient 119, normal, homogenized [OPG study]6.1671960
GSM549108patient 138, normal, homogenized [OPG study]6.4961865
GSM549119patient 077, normal, homogenized [OPG study]6.3850964
GSM549133patient 032, cancer, homogenized [OPG study]6.5819966
GSM549139patient 042, cancer, homogenized [OPG study]6.2020561
GSM549099patient 107, normal, homogenized [OPG study]6.7353169
GSM549109patient 139, normal, homogenized [OPG study]6.2307861
GSM549110patient 046, normal, homogenized [OPG study]6.6075967
GSM549114patient 063, normal, homogenized [OPG study]6.3516364
GSM549122patient 082, normal, homogenized [OPG study]5.9478557
GSM549134patient 033, cancer, homogenized [OPG study]5.9954158
GSM549136patient 036, cancer, homogenized [OPG study]6.0553759
GSM549140patient 044, cancer, homogenized [OPG study]6.2021761
GSM549111patient 047, normal, homogenized [OPG study]6.3477163
GSM549113patient 057, normal, homogenized [OPG study]6.4284964
GSM549132patient 031, cancer, homogenized [OPG study]5.9608758
GSM549137patient 038, cancer, homogenized [OPG study]6.1825961
GSM549142patient 047, cancer, homogenized [OPG study]5.865354
GSM549100patient 110, normal, homogenized [OPG study]6.5003766
GSM549107patient 135, normal, homogenized [OPG study]6.3789264
GSM549115patient 068, normal, homogenized [OPG study]6.3624964
GSM549116patient 072, normal, homogenized [OPG study]6.4516564
GSM549120patient 078, normal, homogenized [OPG study]6.3913464
GSM549131patient 030, cancer, homogenized [OPG study]5.9053957
GSM549118patient 074, normal, homogenized [OPG study]6.122460
GSM549129patient 027, cancer, homogenized [OPG study]6.0645559
GSM549123patient 088, normal, homogenized [OPG study]5.9888458
GSM549124patient 006, cancer, homogenized [OPG study]6.2441462
GSM549126patient 015, cancer, homogenized [OPG study]6.2539462
GSM549128patient 025, cancer, homogenized [OPG study]5.8949156
GSM549103patient 117, normal, homogenized [OPG study]6.2947262
GSM549117patient 073, normal, homogenized [OPG study]6.3014563
GSM549138patient 041, cancer, homogenized [OPG study]6.1933961
GSM549141patient 045, cancer, homogenized [OPG study]6.0624259
GSM549130patient 028, cancer, homogenized [OPG study]5.9931258
GSM549101patient 111, normal, homogenized [OPG study]6.4867865
GSM549105patient 128, normal, homogenized [OPG study]6.6082167
GSM549106patient 134, normal, homogenized [OPG study]6.0776360
GSM549112patient 048, normal, homogenized [OPG study]6.3684164
GSM549125patient 011, cancer, homogenized [OPG study]6.1116660
GSM549127patient 024, cancer, homogenized [OPG study]6.0922459
GSM549135patient 035, cancer, homogenized [OPG study]5.9523458